ARCT · US market

ARCTURUS THERAPEUTICS HOLDINGS INC COM

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$375.47mFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-4.03×

Latest-quarter run-rate P/E-3.95×

Trailing P/S12.78×

Latest-quarter run-rate P/S31.72×

Calculation inputs

Trailing earnings: -US$93.28m
Latest-quarter run-rate earnings: -US$95.14m
Latest fiscal-year earnings: -US$65.78m
Trailing revenue: US$29.37m
Latest-quarter run-rate revenue: US$11.84m
Latest fiscal-year revenue: US$82.03m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

ARKG · ARK Genomic Revolution ETF1.96% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
ARKG.L · ARK Genomic Revolution UCITS ETF1.01% weight · Holdings dated 3 August 2026
BRSDX · MFS Blended Research Small Cap Equity Fund Class A0.09% weight · Holdings dated 31 May 2026
IWC · iShares Micro-Cap ETF0.08% weight · Holdings dated 21 August 2026
WSCJX · Allspring Disciplined Small Cap Fund Class R60.07% weight · Holdings dated 30 June 2026
VSTCX · Vanguard Strategic Small-Cap Equity Fund0.05% weight · Holdings dated 30 June 2026
VTWV · Vanguard Russell 2000 Value ETF0.03% weight · Holdings dated 31 August 2026
PRFZ · Invesco RAFI US 1500 Small-Mid ETF0.03% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
BDSIX · BlackRock Advantage Small Cap Core Fund Institutional Shares0.02% weight · Holdings dated 29 May 2026
IBB · iShares Biotechnology ETF0.02% weight · Holdings dated 19 August 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.